Texas-Squared Startup Newsletter #196

Texas Startup News, Opinion & Events in the Lone StartUP State
View this email in your browser SUBSCRIBE to Texas-Squared

Sign up for reminders about Austin Startup meetups www.bitly.com/txstartupevents
Sign up for the Texas-Boxed CPG Newsletter www.bitly.com/txboxed — APRIL
Download the Texas-Squared Startup Resource Guide PDF

Austin’s Capital Factory looks to grow Houston presence — Link

- The Houston Chronicle’s Andrea Lienfelder

• The Cannon, Capital Factory Announce Partnership — Link
  - The Cannon Blog
• The Cannon and Capital Factory announce new Houston-based partnership — Link
  - Innovation Map’s Natalie Harms

Houston-based AlloVir Raises $120 Million Series B For Virus-Targeting Immunotherapies — Link

- Crunchbase’s Jason D. Rowley

“Houston-based biopharmaceutical company AlloVir (formerly known as ViraCyte) recently announced $120 million in Series B funding. Fidelity Management and Research Company led the deal. Participating investors include Gilead Sciences, F2 Ventures, Invus, Leerink Partners, Redmile Group, EcoR1 Capital, and Samsara BioCapital.”

Help Regina Vatterott with her Recovery — Link